Drug Delivery

Stability in the extreme

Stability in the extreme

The globalisation of the marketplace for pharmaceuticals means that
it is becoming more common for medicines destined for consumption
in the European Union to be manufactured in distant lands. As a
consequence, the EMEA has started...

GMP on the agenda

GMP on the agenda

Mixed news on GMP compliance, as Australia's API has its
manufacturing license renewed after a six-week suspension and GSK
unveils a US FDA probe.

GMP for Atrix

GMP for Atrix

Drug delivery company Atrix Laboratories confirmed this week that
the German regulatory authority, Bundesinstitut fur Arzneimittel
und Medizinprodukte (BfArM), had recently completed a successful
inspection of Atrix's manufacturing...

EU: Investment in R&D slipping

EU: Investment in R&D slipping

European scientists continue to be strong in areas such as medical
research and chemistry and Europe may produce the highest number of
science graduates but it is lagging behind in biotechnology, still
employs fewer researchers, accounts...

Green light for Pfizer

Green light for Pfizer

The European Commission has given Pfizer the all clear to acquire
Pharmacia corporation - paving the way for the creation of the
largest pharmaceutical company in the world.